{"id":30000,"date":"2023-04-13T12:00:43","date_gmt":"2023-04-13T12:00:43","guid":{"rendered":"https:\/\/d36deud6t4mnhi.cloudfront.net\/?page_id=116"},"modified":"2023-06-26T11:21:31","modified_gmt":"2023-06-26T09:21:31","slug":"press-release","status":"publish","type":"page","link":"https:\/\/www.ipsen.com\/us\/press-release\/","title":{"rendered":"Press Releases"},"content":{"rendered":"    <section class=\"sub-page-banner bg-img\" style=\"background-image:url(https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/2\/2023\/04\/02110423\/Module-2E28093hero-image-featured-content_Module-1-banner-Media-releases__rsz_istock-541976598-1920x280-1.png)\">\n        <div class=\"container content-sec\" role=\"main\" id=\"main\">\n            <nav aria-label=\"breadcrumb\">\n            <ol class=\"breadcrumb\">\n                <li class=\"breadcrumb-item\"><a href=\"https:\/\/www.ipsen.com\/us\">Home<\/a><\/li><li class=\"breadcrumb-item active\"><a class=\"link-pointer-events-none\" href=\"#\" aria-current=\"page\">Press Releases<\/a><\/li><\/ol>\n            <\/nav>            <h1 class=\"visible\">Press Releases<\/h1>\n            <p class=\"visible\">A comprehensive library of Ipsen media releases for investors and members of the press. <\/p>\n        <\/div>\n    <\/section>\n\n\n\n<section class=\"media-filter\">\n    <div class=\"container media-filter-inner\">\n                <h2 class=\"media-filter-title charcoal-grey\">Explore press releases<\/h2>\n                <div class=\"media-filter-main\" id=\"search-total-div\" data-langaugecode=\"\" data-paginationtype=\"visible\" data-loadmore=\"hidden\" data-filtertype=\"pressrelease\" data-posttype=\"press_release\"\n            data-pagination=\"visible\" data-parenttermid=\"[556,568,535,566]\">\n            <div class=\"row\">\n                <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                                        <!-- media drop down -->\n                    <div class=\"media-drop-down\">\n                        <p class=\"media-drop-heading\">Filter<\/p>\n                        <div class=\"media-dropdown-items\">\n                            <div class=\"row\">\n                                                            <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                                    <div class=\"topic-filter\">\n                                                                                <p>Topics<\/p>\n                                                                                <div class=\"mutltiselect-dropdown topic-cat-dropdown\">\n                                            <select name=\"langOpt[]\" multiple id=\"topicOpt\">\n                                                                                                <option value=\"556\">Corporate                                                <\/option>\n                                                                                                <option value=\"568\">Oncology                                                <\/option>\n                                                                                                <option value=\"535\">Rare Diseases                                                <\/option>\n                                                                                                <option value=\"566\">Neuroscience                                                <\/option>\n                                                                                            <\/select>\n                                        <\/div>\n                                    <\/div>\n                                <\/div>\n                                                                                                                                <div class=\"column-2 col-lg-4 col-md-4 col-sm-12\">\n                                    <div class=\"period-filter\">\n                                            <p>Period<\/p>\n                                          <div class=\"mutltiselect-dropdown year-dropdown\">\n                                            <select name=\"langOpt[]\" multiple id=\"periodOpt\">\n                                                                                            <option value=\"2025\">2025                                                                                            <option value=\"2024\">2024                                                                                            <option value=\"2023\">2023                                                                                            <option value=\"2022\">2022                                                                                            <option value=\"2021\">2021                                                                                            <option value=\"2020\">2020                                                                                            <option value=\"2019\">2019                                                                                            <option value=\"2018\">2018                                                                                            <option value=\"2017\">2017                                                                                            <option value=\"2016\">2016                                                                                        <\/select>\n                                        <\/div>\n                                    <\/div>\n                                <\/div>\n                                \n                                                                                                            <div class=\"column-3 col-lg-4 col-md-4 \">\n                                            <div class=\"filterby-filter\">\n                                                <p>Filter by<\/p>\n                                                <div class=\"input-filter\">\n                                                    <input type=\"search\" name=\"filter-by\" id=\"filter-by\"\n                                                        placeholder=\"Type a keyword\">\n                                                <\/div>\n                                                <div class=\"filter-by-dropdown\">\n                                                    <p class=\"recent\">recent search<\/p>\n                                                                                                        <ul class=\"filter-by-list\">\n                                                                                                            <\/ul>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                                                                                                              <\/div>\n                            <div class=\"reset-btn-div\">\n                                <a href=\"#\" class=\"reset-btn\">Reset<\/a>\n                            <\/div>\n                        <\/div>\n                    <\/div>\n                                        <!-- sorting section -->\n                    \t\t\t\t\t\t\n        <section class=\"media-filter\">\n            <div class=\"container media-filter-inner\">\n                <div class=\"media-filter-main\" id=\"search-total-div\" data-langaugecode=\"en\" data-paginationtype=\"visible\" data-loadmore=\"hidden\" data-filtertype=\"investor-event\" data-posttype=\"event\" data-pagination=\"visible\" data-parenttermid=\"[492,493,1810,494]\">\n                    <div class=\"row\">\n                        <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                        <div class=\"sorting-sec\">\n                            <div class=\"row\">\n                                                                    <div class=\"column-1 col-xl-6 col-lg-6 col-sm-12\">\n                                        <div class=\"no-of-item-sec\">\n                                            <p>Showing: <span id=\"start-value\">1<\/span> &#8211; <span id=\"no-of-search\">05<\/span> of <span id=\"total-count\">25<\/span>\n                                                <\/p>\n                                        <\/div>\n                                    <\/div>\n                                                                <div class=\"column-2 col-xl-6 col-lg-6 col-sm-12\">\n                                                                            <div class=\"sort-input\">\n                                            <div class=\"sort-input-inner\">\n                                            <label for=\"sorting-input\">Show<\/label>\n                                                                                            <select name=\"order\" aria-label=\"5\" id=\"show-list\">\n                                                    <option value=\"05\" selected>05<\/option>\n                                                    <option value=\"10\" >10<\/option>\n                                                    <option value=\"20\" >20<\/option>\n                                                    <option value=\"30\" >30<\/option>\n                                                    <option value=\"40\" >40<\/option>\n                                                    <option value=\"50\" >50<\/option>\n                                                <\/select>\n                                            <\/div>\n                                        <\/div>\n\t\t\t\t\t\t\t\t\n                                                                                                                <div class=\"sort-input-ascending\">\n                                            <div class=\"sort-input-ascending-inner\">\n                                                <label for=\"sorting-input-ascend\">Sort<\/label>\n                                                <select name=\"sorting-input-ascend\" id=\"show-list-as\" class=\"show-list-as\">\n                                                    <option value=\"DESC\" aria-label=\"Descending\" selected>Descending<\/option>\n                                                    <option value=\"ASC\" aria-label=\"Ascending\"  >Ascending<\/option>                                                    \n                                                <\/select>\n                                            <\/div>\n                                        <\/div>                                        \n                                                                    <\/div>\n                            <\/div>\n                        <\/div>\n                        <\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\n\t\t<\/section>\n                                       \n                    <!-- Search listing include start here-->\n                    <div id=\"search-results\" class=\"story-div\">\n                        <!-- Press Release Listing start here -->\n<div class=\"story-div\" id=\"search-div\">\n\t<div>\n<div class=\"row story-row pr-card\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                        <div class=\"story-img\">\n                                            <a href=\"https:\/\/www.ipsen.com\/us\/press-releases\/bylvay-odevixibat-data-shows-sustained-improvement-in-severe-itch-and-serum-bile-acid-levels-in-patients-with-pfic-and-algs-2982434\/\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/2\/2023\/05\/02112724\/PR-final.jpg\" alt=\"Bylvay\u00ae (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS\" title=\"Bylvay\u00ae (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS\"\/><\/a>\n                                    <\/div>\n            <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#224a81\">\n                        Rare Diseases                    <\/button>\n                    <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/us\/wp-content\/themes\/ipsen-main\/dist\/images\/radio.png\"\n                        class=\"radio-img desk-span\" alt=\"Press Release Icon\" title=\"Press Release Icon\" width=\"auto\">\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">18 November 2024                            <!-- <span class=\"story-read-time\">12 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">18 November 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                <div class=\"download\">\n                    <a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/355fddf1-a1ef-4c57-b449-a09729386b32\" download>\n                        <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/us\/wp-content\/themes\/ipsen-main\/dist\/images\/download.png\" alt=\"Download\" title=\"Download\"\/>\n                    <\/a>\n                <\/div>\n                                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/us\/press-releases\/bylvay-odevixibat-data-shows-sustained-improvement-in-severe-itch-and-serum-bile-acid-levels-in-patients-with-pfic-and-algs-2982434\/\">\n                        <h5 class=\"blue-txt\">Bylvay\u00ae (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS<\/h5>\n                    <\/a>\n                    <p class=\"second-post-para\">PARIS, FRANCE, 18 November, 2024 Ipsen (Euronext: IPN; ADR: IPSEY) today announced data at the American Association for the Study of Liver Diseases (AASLD) assessing the long-term efficacy and safety of patients treated with Bylvay\u00ae from two Phase III open-label&#8230;<\/p>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\t\t\n<\/div>\n<br>\n\t\t\t<div>\n<div class=\"row story-row pr-card\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                        <div class=\"story-img\">\n                                            <a href=\"https:\/\/www.ipsen.com\/us\/press-releases\/iqirvo-elafibranor-data-shows-efficacy-and-safety-for-up-to-3-years-in-patients-with-pbc-with-improvements-in-fatigue-and-pruritus-2982128\/\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/2\/2023\/05\/02112724\/PR-final.jpg\" alt=\"Iqirvo\u00ae (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus\" title=\"Iqirvo\u00ae (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus\"\/><\/a>\n                                    <\/div>\n            <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#224a81\">\n                        Rare Diseases                    <\/button>\n                    <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/us\/wp-content\/themes\/ipsen-main\/dist\/images\/radio.png\"\n                        class=\"radio-img desk-span\" alt=\"Press Release Icon\" title=\"Press Release Icon\" width=\"auto\">\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">15 November 2024                            <!-- <span class=\"story-read-time\">12 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">15 November 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                <div class=\"download\">\n                    <a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/aff95761-691f-40e8-a64d-c1713222bf44\" download>\n                        <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/us\/wp-content\/themes\/ipsen-main\/dist\/images\/download.png\" alt=\"Download\" title=\"Download\"\/>\n                    <\/a>\n                <\/div>\n                                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/us\/press-releases\/iqirvo-elafibranor-data-shows-efficacy-and-safety-for-up-to-3-years-in-patients-with-pbc-with-improvements-in-fatigue-and-pruritus-2982128\/\">\n                        <h5 class=\"blue-txt\">Iqirvo\u00ae (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus<\/h5>\n                    <\/a>\n                    <p class=\"second-post-para\">PARIS, FRANCE, 15 November 2024 Ipsen (Euronext: IPN; ADR: IPSEY) announced today late-breaking data for Iqirvo\u00ae (elafibranor 80 mg tablets) from an interim analysis of the ongoing open-label extension of the Phase III ELATIVE\u00ae study at the American Association for&#8230;<\/p>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\t\t\n<\/div>\n<br>\n\t\t\t<div>\n<div class=\"row story-row pr-card\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                        <div class=\"story-img\">\n                                            <a href=\"https:\/\/www.ipsen.com\/us\/press-releases\/ipsens-iqirvo-receives-u-s-fda-accelerated-approval-as-a-first-in-class-ppar-treatment-for-primary-biliary-cholangitis\/\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/2\/2023\/05\/02112724\/PR-final.jpg\" alt=\"Ipsen\u2019s Iqirvo\u00ae receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis\" title=\"Ipsen\u2019s Iqirvo\u00ae receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis\"\/><\/a>\n                                    <\/div>\n            <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#224a81\">\n                        Rare Diseases                    <\/button>\n                    <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/us\/wp-content\/themes\/ipsen-main\/dist\/images\/radio.png\"\n                        class=\"radio-img desk-span\" alt=\"Press Release Icon\" title=\"Press Release Icon\" width=\"auto\">\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">10 June 2024                            <!-- <span class=\"story-read-time\">12 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">10 June 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                <div class=\"download\">\n                    <a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/f4dcd41e-59b6-4a46-b0d7-fda061921470\" download>\n                        <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/us\/wp-content\/themes\/ipsen-main\/dist\/images\/download.png\" alt=\"Download\" title=\"Download\"\/>\n                    <\/a>\n                <\/div>\n                                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/us\/press-releases\/ipsens-iqirvo-receives-u-s-fda-accelerated-approval-as-a-first-in-class-ppar-treatment-for-primary-biliary-cholangitis\/\">\n                        <h5 class=\"blue-txt\">Ipsen\u2019s Iqirvo\u00ae receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis<\/h5>\n                    <\/a>\n                    <p class=\"second-post-para\">PARIS, FRANCE, 10 June 2024 &nbsp;Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Iqirvo\u00ae (elafibranor) 80 mg tablets for the treatment of primary biliary cholangitis (PBC) in combination&#8230;<\/p>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\t\t\n<\/div>\n<br>\n\t\t\t<div>\n<div class=\"row story-row pr-card\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                        <div class=\"story-img\">\n                                            <a href=\"https:\/\/www.ipsen.com\/us\/press-releases\/ipsen-presents-long-term-elafibranor-efficacy-and-itch-related-quality-of-life-data-in-patients-with-primary-biliary-cholangitis-2\/\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/2\/2023\/05\/02112724\/PR-final.jpg\" alt=\"Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with primary biliary cholangitis\u00a0\u00a0\u00a0\u00a0\" title=\"Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with primary biliary cholangitis\u00a0\u00a0\u00a0\u00a0\"\/><\/a>\n                                    <\/div>\n            <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#224a81\">\n                        Rare Diseases                    <\/button>\n                    <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/us\/wp-content\/themes\/ipsen-main\/dist\/images\/radio.png\"\n                        class=\"radio-img desk-span\" alt=\"Press Release Icon\" title=\"Press Release Icon\" width=\"auto\">\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">05 June 2024                            <!-- <span class=\"story-read-time\">7 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">05 June 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                <div class=\"download\">\n                    <a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/1e610d8c-b9c6-458c-b047-e282feb68d1e\" download>\n                        <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/us\/wp-content\/themes\/ipsen-main\/dist\/images\/download.png\" alt=\"Download\" title=\"Download\"\/>\n                    <\/a>\n                <\/div>\n                                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/us\/press-releases\/ipsen-presents-long-term-elafibranor-efficacy-and-itch-related-quality-of-life-data-in-patients-with-primary-biliary-cholangitis-2\/\">\n                        <h5 class=\"blue-txt\">Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with primary biliary cholangitis\u00a0\u00a0\u00a0\u00a0<\/h5>\n                    <\/a>\n                    <p class=\"second-post-para\">PARIS, FRANCE, 5 June 2024\u00a0Ipsen (Euronext: IPN; ADR: IPSEY) today announced new late-breaking data at the European Association for the Study of the Liver (EASL) Congress demonstrating the enduring efficacy of elafibranor in managing disease progression after 78 weeks of&#8230;<\/p>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\t\t\n<\/div>\n<br>\n\t\t\t<div>\n<div class=\"row story-row pr-card\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                        <div class=\"story-img\">\n                                            <a href=\"https:\/\/www.ipsen.com\/us\/press-releases\/ipsen-appoints-keira-driansky-as-evp-president-of-north-america\/\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/2\/2023\/05\/02112724\/PR-final.jpg\" alt=\"Ipsen appoints Keira Driansky as EVP, President of North America\" title=\"Ipsen appoints Keira Driansky as EVP, President of North America\"\/><\/a>\n                                    <\/div>\n            <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#4e6e9a\">\n                        Corporate                    <\/button>\n                    <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/us\/wp-content\/themes\/ipsen-main\/dist\/images\/radio.png\"\n                        class=\"radio-img desk-span\" alt=\"Press Release Icon\" title=\"Press Release Icon\" width=\"auto\">\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">02 May 2024                            <!-- <span class=\"story-read-time\">5 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">02 May 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                <div class=\"download\">\n                    <a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/d1f9afd9-fc96-4115-984f-e187ff9fa55c\" download>\n                        <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/us\/wp-content\/themes\/ipsen-main\/dist\/images\/download.png\" alt=\"Download\" title=\"Download\"\/>\n                    <\/a>\n                <\/div>\n                                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/us\/press-releases\/ipsen-appoints-keira-driansky-as-evp-president-of-north-america\/\">\n                        <h5 class=\"blue-txt\">Ipsen appoints Keira Driansky as EVP, President of North America<\/h5>\n                    <\/a>\n                    <p class=\"second-post-para\">PARIS, FRANCE, 2 May 2024 &#8211; Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Keira Driansky as EVP, President of North America, effective May 13, 2024. She will serve on the Executive Leadership&#8230;<\/p>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\t\t\n<\/div>\n<br>\n\t\t\t<div class=\"pagination\"><span class='page-numbers current'>1<\/span><a class='page-numbers' onclick='paginationClick(2)'>2<\/a><span class='page-numbers dots'>&#8230;<\/span><a class='page-numbers' onclick='paginationClick(5)'>5<\/a><a class='next page-numbers' onclick='paginationClick(2)'><\/a><\/div><\/div>\n<!-- Press Release Listing Ends here -->\n                        <!-- Search listing include end here-->\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-30000","page","type-page","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ipsen media releases<\/title>\n<meta name=\"description\" content=\"A comprehensive feed of Ipsen media releases intended for investors and members of the press, plus contact details for press liaison.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/us\/press-release\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen media releases\" \/>\n<meta property=\"og:description\" content=\"A comprehensive feed of Ipsen media releases intended for investors and members of the press, plus contact details for press liaison.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/us\/press-release\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-26T09:21:31+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/us\/press-release\/\",\"url\":\"https:\/\/www.ipsen.com\/us\/press-release\/\",\"name\":\"Ipsen media releases\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/us\/#website\"},\"datePublished\":\"2023-04-13T12:00:43+00:00\",\"dateModified\":\"2023-06-26T09:21:31+00:00\",\"description\":\"A comprehensive feed of Ipsen media releases intended for investors and members of the press, plus contact details for press liaison.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/us\/press-release\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/us\/press-release\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/us\/press-release\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/us\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Press Releases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/us\/#website\",\"url\":\"https:\/\/www.ipsen.com\/us\/\",\"name\":\"United States\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/us\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/us\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/us\/#organization\",\"name\":\"United States\",\"url\":\"https:\/\/www.ipsen.com\/us\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/us\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/2\/2023\/12\/07162616\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/2\/2023\/12\/07162616\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"United States\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/us\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen media releases","description":"A comprehensive feed of Ipsen media releases intended for investors and members of the press, plus contact details for press liaison.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/us\/press-release\/","og_locale":"en_US","og_type":"article","og_title":"Ipsen media releases","og_description":"A comprehensive feed of Ipsen media releases intended for investors and members of the press, plus contact details for press liaison.","og_url":"https:\/\/www.ipsen.com\/us\/press-release\/","og_site_name":"United States","article_modified_time":"2023-06-26T09:21:31+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/us\/press-release\/","url":"https:\/\/www.ipsen.com\/us\/press-release\/","name":"Ipsen media releases","isPartOf":{"@id":"https:\/\/www.ipsen.com\/us\/#website"},"datePublished":"2023-04-13T12:00:43+00:00","dateModified":"2023-06-26T09:21:31+00:00","description":"A comprehensive feed of Ipsen media releases intended for investors and members of the press, plus contact details for press liaison.","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/us\/press-release\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/us\/press-release\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/us\/press-release\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/us\/"},{"@type":"ListItem","position":2,"name":"Press Releases"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/us\/#website","url":"https:\/\/www.ipsen.com\/us\/","name":"United States","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/us\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/us\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/us\/#organization","name":"United States","url":"https:\/\/www.ipsen.com\/us\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/us\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/2\/2023\/12\/07162616\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/2\/2023\/12\/07162616\/Latest_Ipsen-logo_168x48.svg","caption":"United States"},"image":{"@id":"https:\/\/www.ipsen.com\/us\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/us\/wp-json\/wp\/v2\/pages\/30000","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/us\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ipsen.com\/us\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/us\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/us\/wp-json\/wp\/v2\/comments?post=30000"}],"version-history":[{"count":12,"href":"https:\/\/www.ipsen.com\/us\/wp-json\/wp\/v2\/pages\/30000\/revisions"}],"predecessor-version":[{"id":41189,"href":"https:\/\/www.ipsen.com\/us\/wp-json\/wp\/v2\/pages\/30000\/revisions\/41189"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/us\/wp-json\/wp\/v2\/media?parent=30000"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}